Loading…
Lijiang Biotechnology held a groundbreaking ceremony for a disposable blood perfusion device project in Weixian, Hebei, China. The project has a planned investment of 200 million RMB and is expected to be completed in 2021, with an annual capacity of 1 million devices.
| Site | Largest | Latest |
|---|---|---|
| Weixian, China | $29.8M | 2019-02-25 |